Immune system
A peptide drug approved in Japan as an add-on cancer therapy — it boosts immune-cell activity while blocking enzymes some cancer cells rely on.
Start here
Bestatin, also called ubenimex, is a small compound taken by mouth that supports the immune system by blocking enzymes that break down the peptide signals immune cells use to communicate 1. It is approved in Japan as an add-on cancer therapy, and in people with a form of acute leukemia it prolonged survival after remission. In the US it remains a research compound without FDA approval.
Bestatin is a small molecule immunomodulator that enhances immune function by preventing the breakdown of important immune-signaling peptides. It works by inhibiting aminopeptidases (an enzyme that trims proteins), enzymes that degrade peptide hormones used by immune cells for communication. This extends the activity of these immune signals, boosting T cell function and natural killer cell activity against infections and cancer 1.
Bestatin (ubenimex) blocks three enzymes by competing with their normal targets: aminopeptidase (an enzyme that trims proteins) B (APB), leucine aminopeptidase (LAP), and leukotriene A4 hydrolase (LTA4H). 15 It boosts the immune system through several routes at once. (1) It blocks aminopeptidases (enzymes that trim proteins) on the surface of antigen-presenting cells (cells that show pieces of invaders to the immune system). This improves MHC class I antigen processing and presentation (the way cells display protein fragments to killer T-cells), so more CD8+ cytotoxic T-lymphocytes (killer immune cells) switch on. (2) Activated macrophages (immune cells that engulf invaders) make more interleukin-1 (IL-1). IL-1 drives T-helper cells (immune coordinator cells) to multiply and release IL-2, which strengthens the adaptive immune response (the part of immunity that learns and targets specific threats). 1 (3) It directly activates macrophages, so they engulf more, make more reactive oxygen species (chemicals that damage cells), and kill tumor cells better. (4) It stimulates bone marrow colony-forming units (CFU-GM, BFU-E, the starter cells for blood cells), which helps blood cell recovery after therapy that suppresses the bone marrow. 13 Its anti-inflammatory action centers on blocking LTA4H. This stops the conversion of leukotriene A4 into leukotriene B4 (LTB4), a strong attractant for neutrophils (a type of white blood cell) and a driver of inflammation. 5 In pulmonary arterial hypertension (high blood pressure in the lung arteries), LTB4 drives macrophage buildup, smooth muscle cell growth, and remodeling of the small lung arteries. 5 By lowering LTB4, bestatin may reduce these harmful processes. Its structure is a phenylalanine-leucine dipeptide analogue (a look-alike of a two-amino-acid unit) with a unique (2S,3R)-3-amino-2-hydroxy group. This lets it bind precisely to the zinc-containing active sites (the working pockets) of its target enzymes.
Evidence check
Some human studies
It has been tested in people, but only in small or early-stage studies. Promising, but not yet proven the way an approved medicine is.
Every numbered marker on this page links to one of the 10 sources at the bottom.
Immune
Bestatin is a well-studied immune booster that activates T-cells, macrophages, and natural killer cells (all immune cells) and increases IL-1 and IL-2 (signals that rev up immune cells). It is approved in Japan as an add-on immune treatment for acute non-lymphocytic leukemia (a fast-growing blood cancer), with decades of clinical evidence for its immune-boosting effects.
Healing & Recovery
By stimulating bone marrow stem cells to multiply and helping the immune system recover after chemotherapy, bestatin supports the body's rebuilding processes during cancer treatment. Clinical trials showed longer survival in AML patients (a type of blood cancer) who reach complete remission, meaning no detectable cancer.
Anti-Aging
Bestatin's ability to enhance immune surveillance and modulate inflammatory pathways through LTA4 hydrolase inhibition has potential implications for age-related immune decline and chronic inflammatory conditions, though direct anti-aging research is limited.
The most-asked question
The research-reported range is 30 mg, once daily.
Leukemia maintenance, Immune support
30 mg
30 mg by mouth once daily is the approved Japanese dose, used as add-on treatment after leukemia goes into remission (no detectable cancer). It helped patients, especially older adults, stay in remission longer 41.
The ceiling: 100 mg once daily (as established in Phase 1 clinical trials) 1
Reconstitution, in plain words
Peptides usually arrive as a freeze-dried powder in a small vial. “Reconstitution” just means adding sterile water back in so you can measure a dose. Here's how it works for Bestatin (Ubenimex):
Bestatin (Ubenimex) comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.
Use Bestatin (Ubenimex) exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.
Three quick questions — your vial, your water, your dose — and it tells you the exact syringe mark. “Find dose amount” is preloaded with Bestatin (Ubenimex)'s recorded schedule.
Timing
Take Bestatin (Ubenimex) at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.
Bestatin (Ubenimex) can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.
Bestatin (Ubenimex) should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
The honest list
These show up most often. They usually fade as your body adjusts.
Mild nausea, diarrhea, or abdominal discomfort are the most frequently reported side effects with oral bestatin. These are typically transient and occur during the first week of treatment 10.
What to do Take with a small amount of food or water if stomach upset occurs. Symptoms usually resolve within a few days of continued use. If persistent, consider temporary dose reduction.
Mild skin reactions including rash, itching, or urticaria have been reported in a subset of patients. These are generally mild and do not require discontinuation 10.
What to do Antihistamines may provide symptomatic relief. If rash is widespread or accompanied by systemic (affecting the whole body) symptoms, discontinue and consult healthcare provider. Usually resolves within days of stopping treatment.
Transient facial flushing or warmth may occur, particularly during the initial days of treatment, likely related to immune activation and histamine release.
What to do Usually self-limiting and resolves within 30-60 minutes of dosing. No treatment required. If persistent or bothersome, dose reduction may help.
Mild fatigue or malaise may occur as the immune system is stimulated. This is more commonly noted in patients concurrently receiving chemotherapy.
What to do Ensure adequate rest and hydration. Fatigue typically improves after the first 1-2 weeks of treatment. May be managed with dose timing adjustment to evening if daytime fatigue is problematic.
Worth knowing about, but most people never see these.
Transient elevations in AST and ALT have been reported, particularly with higher doses or prolonged treatment. This is usually mild and asymptomatic 10.
What to do Regular monitoring of liver function tests is recommended, especially during the first months of treatment. If transaminases exceed 3x the upper limit of normal, consider dose reduction or discontinuation.
A mild, usually transient decrease in white blood cell count may occur, particularly in patients already immunocompromised from chemotherapy.
What to do Monitor complete blood counts regularly. Mild leukopenia is often self-resolving. If white cell count drops significantly, hold treatment and consult oncologist.
Rare, but if any of these happen, stop and contact a medical professional.
In rare cases, severe allergic reactions can occur, including deep swelling of the face or throat (angioedema) or symptoms resembling a whole-body allergic emergency (anaphylaxis). This is extremely uncommon given how small the bestatin molecule is.
What to do Discontinue immediately and seek emergency medical attention. Patients with a history of severe drug allergies should be monitored closely during initial dosing. Have emergency medications available for first doses.
Week by week
Is it right for you?
Always consult with your healthcare provider before stopping bestatin, especially during cancer treatment. Abrupt discontinuation during AML maintenance therapy should only be done under medical supervision.
Bestatin is specifically designed and approved to be used alongside AML (acute myeloid leukemia, a fast-growing blood cancer) chemotherapy. Clinical trials showed combined benefits with standard induction and maintenance regimens (the first and the follow-up phases of chemotherapy).
Bestatin boosts the immune system, which directly works against drugs that hold it back. Avoid using them together, or use them together only with careful immune monitoring.
Bestatin blocks aminopeptidases (enzymes that trim proteins) involved in handling angiotensin (a blood pressure hormone), which may make the blood-pressure-lowering effect of ACE inhibitors stronger. Monitor blood pressure closely if used together.
No known negative interactions with common antibiotics. Bestatin may support antibiotic treatment by helping the immune system clear infections.
Both boost immune function in ways that complement each other. Thymosin Alpha-1 helps T-cells (immune cells that attack infected or abnormal cells) mature in the thymus (a gland in the chest), while bestatin helps T-cells in the rest of the body switch on. The combination may give extra immune support but should be watched for too much immune stimulation.
Boosts the immune system in ways that complement bestatin. TP-5 adjusts how the thymus (a gland in the chest) works, while bestatin acts on aminopeptidases (enzymes that trim proteins). No known negative interactions, but the combination has not been studied much.
BPC-157 focuses on tissue repair while bestatin targets immune function. Their effects do not overlap and no interactions are known. Can likely be used at the same time without problems.
Vitamin D supports immune function in ways that complement bestatin and may strengthen bestatin's immune-boosting effects. Safe to combine.
Zinc is essential for immune cells to work properly and for T-lymphocytes (immune cells that attack infected or abnormal cells) to develop. May support bestatin's immune-boosting effects. Safe to combine.
EGCG (a compound in green tea) can also block aminopeptidases (enzymes that trim proteins), which may overlap with bestatin. While generally safe, combining several aminopeptidase blockers may add up their effects. Use with awareness.
Bestatin is approved in Japan for adults with acute non-lymphocytic leukemia (a fast-growing blood cancer) who are in complete remission, meaning no detectable cancer, after their first round of chemotherapy. 10 Clinical trials showed that adding bestatin to standard maintenance treatment significantly lengthened the time patients stayed free of disease 34.
Bestatin helps the bone marrow make more stem cells (the cells that become blood cells) and helps T-cells and macrophages (immune cells) work better. This supports immune recovery in patients whose immune system was weakened by chemotherapy 13.
Through inhibition of LTA4 hydrolase and reduction of pro-inflammatory leukotriene B4, 5 bestatin is being investigated as a novel approach to PAH. Eiger BioPharmaceuticals conducted Phase 2 trials (NCT02664558) 7 and received FDA orphan drug designation for this indication 9.
Bestatin calms inflammation by blocking the LTB4 pathway (a chemical route that drives inflammation). That led to a Phase 2 trial (NCT02700529) 8 in lymphedema (chronic swelling from fluid build-up), a condition with few treatments where inflammation plays a key role.
Bestatin (ubenimex) has an established safety record from decades of clinical use in Japan at 30 mg daily to help keep AML (a type of blood cancer) in remission. 310 It is generally well tolerated; the most common side effects are mild stomach upset and skin reactions. 10 Japan's long-term monitoring after approval has not found major safety concerns at standard doses. Phase 2 trials in the US for pulmonary arterial hypertension (high blood pressure in the lungs' arteries) and lymphedema (chronic limb swelling) 78 also showed acceptable safety at higher doses.
Safety data is supported by Japanese regulatory approval, Phase 1-2 clinical trials, and decades of post-marketing surveillance. FDA orphan drug designation for PAH 9 indicates adequate safety data for continued clinical development. Most safety data comes from Japanese clinical experience; data in non-Japanese populations is more limited.
Keeping it good
Store Bestatin (Ubenimex) in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
Once reconstituted, Bestatin (Ubenimex) should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Not our opinion — the published record
1987
Bestatin works by blocking enzymes on immune cells, which lets important immune signals last longer and boosts T-cell activity (T-cells are immune cells that attack infected or abnormal cells). When mice with cancer got bestatin combined with chemotherapy, they lived much longer than those getting chemo alone. This shows the drug strongly strengthens the body's cancer-fighting immune response.
Tsukagoshi S
1992
Leukemia patients taking 30 mg daily of bestatin showed major improvements in their natural killer cells and T-lymphocytes (two kinds of immune cells that kill abnormal cells). These immune benefits stayed strong throughout treatment and helped patients better fight off their cancer while recovering from chemotherapy.
Hiraoka A, Shibata H, Masaoka T
1990
Bestatin jumpstarted the bone marrow's ability to recover after chemotherapy wiped it out, rebuilding immune cell numbers faster than normal. The drug especially boosted CD4+ T-cells (the immune cells that coordinate immune attacks), making it a powerful tool for patients rebuilding their defenses after cancer treatment.
Ota K, Ogawa N
1991
AML patients (people with acute myeloid leukemia, a fast-growing blood cancer) who took bestatin 30 mg daily after chemotherapy put them in remission stayed cancer-free much longer than those on placebo. The peptide worked by cranking up production of IL-1 and IL-2, the chemical messengers that rev up immune cells to attack any remaining cancer cells.
Ota K
2013
Scientists discovered bestatin blocks an enzyme that makes leukotriene B4, a strong inflammation-causing chemical that damages lung blood vessels. This anti-inflammatory action opened up a completely new use for bestatin: possibly treating pulmonary arterial hypertension (high blood pressure in the lung arteries), a serious lung disease where inflammation scars the arteries.
Tian W, Jiang X, Tamosiuniene R, et al.
1976
The original 1976 discovery report in the Journal of Antibiotics: bestatin was isolated from a culture of actinomycetes (a group of soil bacteria) as a blocker of aminopeptidase B (an enzyme that trims proteins).
Umezawa H, Aoyagi T, Suda H, Hamada M, Takeuchi T
2016
A completed Phase 2 trial (a mid-stage trial, with random assignment and a placebo group) of ubenimex in pulmonary arterial hypertension (high blood pressure in the lung arteries), sponsored by Eiger BioPharmaceuticals.
Eiger BioPharmaceuticals
2016
A completed Phase 2 trial (a mid-stage trial) of ubenimex in lymphedema of the legs (swelling from fluid buildup), sponsored by Eiger BioPharmaceuticals.
Eiger BioPharmaceuticals
2015
Announcement from the sponsor: the FDA granted orphan drug designation (a status for drugs treating rare diseases) to ubenimex for the treatment of PAH (pulmonary arterial hypertension, high blood pressure in the lung arteries) on November 30, 2015. It states that ubenimex blocks two kinds of enzymes, aminopeptidases and LTA4 hydrolase, has been used for over 25 years in Japan, and is marketed by Nippon Kayaku as Bestatin.
Eiger BioPharmaceuticals (PR Newswire)
If this isn't the right fit
Your questions
Bestatin and ubenimex are two names for the same compound. "Bestatin" is the original laboratory name given by its discoverer Hamao Umezawa in 1976, 6 while "Ubenimex" is the official international drug name used for the approved pharmaceutical product. In Japan, it is sold under the brand name Bestatin by Nippon Kayaku Co., Ltd. 910 Both names refer to the same small two-part protein fragment that blocks aminopeptidases (enzymes that trim proteins).
No, bestatin (ubenimex) is not currently FDA-approved. Japan has approved and used it since the 1980s as an add-on immune therapy for acute non-lymphocytic leukemia (a type of blood cancer). 10 In the United States, it has FDA orphan drug status (a designation for rare-disease treatments) for pulmonary arterial hypertension (high blood pressure in the lungs' arteries), 9 and Phase 2 clinical trials have been run for that condition and for lymphedema (chronic limb swelling) by Eiger BioPharmaceuticals. 78 While not FDA-approved, decades of Japanese clinical use back up its safety and effectiveness.
Bestatin is a pharmaceutical-grade compound with a very specific job—it blocks three enzymes: aminopeptidase (an enzyme that trims proteins) B, leucine aminopeptidase, and LTA4 hydrolase. 15 General immune supplements broadly rev up immune activity. Bestatin instead works through precise enzyme-blocking that helps immune cells recognize threats, activates T cells (a kind of white blood cell), and improves the work of macrophages (immune cells that swallow germs)—while also cutting production of leukotrienes (chemicals that drive inflammation). It has been tested in randomized clinical trials and holds regulatory approval in Japan, 10 setting it apart from over-the-counter immune products.
Yes. Bestatin was developed and approved for leukemia, but the way it works has opened other doors. Eiger BioPharmaceuticals ran Phase 2 trials for pulmonary arterial hypertension (high blood pressure in the lungs' arteries, NCT02664558) 7 and lymphedema (chronic limb swelling, NCT02700529), 8 using bestatin's ability to block LTA4 hydrolase (an enzyme that drives inflammation and harmful blood-vessel changes). 5 Research has also explored its potential in solid tumors, autoimmune conditions, and as a broad immune booster for people with weakened immune systems.
The standard therapeutic dose used in Japanese clinical practice is 30 mg once daily, taken orally. 10 Phase 1 clinical trials established an optimal dose range of 10-100 mg daily. 1 For leukemia maintenance, 30 mg daily is standard. 3 For investigational indications like PAH, higher doses may be used under physician supervision. Treatment duration varies by indication — in AML maintenance, courses typically extend for 1-2 years or longer.
Bestatin was discovered in 1976 by Professor Hamao Umezawa and his team at the Institute of Microbial Chemistry in Tokyo, Japan. They isolated it from a soil bacterium called Streptomyces olivoreticuli. 16 Umezawa was a pioneer in finding enzyme-blocking compounds from microbes and discovered other important compounds too. Bestatin turned up in a screen for small molecules that block aminopeptidases (enzymes that trim proteins), and its immune-boosting and anti-tumor properties were worked out afterward.
Bestatin is generally well-tolerated, with most side effects being mild and transient. Common effects include mild GI discomfort, skin rash, 10 and facial flushing. Uncommon effects include transient liver enzyme elevations and mild decreases in white blood cell counts. Serious side effects such as severe allergic reactions are rare. Long-term Japanese clinical experience over decades has confirmed a favorable safety profile at the standard 30 mg daily dose. 34 Liver function monitoring is recommended during treatment.
10 sources
Every numbered marker on this page points to one of these. Same sources, same numbering as the Bestatin (Ubenimex) research profile on Peptide Initiative.
Want the deep science?
Every claim on this page traces back to the research database behind Peptide Initiative — studies, citations, clinical trial data, and the technical detail we deliberately left out here.
Open the research profileThis guide is education, not medical advice. Talk to a clinician before taking anything.
PeptideGeek